Management of intracranial tumours in the acute setting

Warning

Guidelines for use of steroids for primary & metastatic intra-cranial lesions (GG/4)

The flow chart in the section below shows the acute medical guidelines for initial management of newly diagnosed brain lesion. 

Patients with known cancer and brain metastases should be discussed with a site specialist oncologist (if not urgent contact their oncology consultant or if urgent via on call oncology STR).  

Referral to neuro-surgery or ECNO MDM only indicated when surgery or radiosurgery (SRS) are being considered (see OOQS for referral guidance) - only available on NHS Lothian intranet. 

Edinburgh Centre for Neuro-oncology guidance for the management of intracranial tumours in the acute setting

Edinburgh Centre for Neuro-oncology guidance for the management of intracranial tumours in the acute setting

This algorithm aids clinical decision making for patients presenting to the Emergency Department / Acute Receiving Unit with an intracranial lesion felt to most likely represent a primary brain tumour or metastatic deposit. Many of the frequently asked questions are answered in the further information sections of the algorithm but specialist help should be sought for any additional queries not answered within this guidance. 

Please direct any comments, questions or feedback to Dr S Erridge, Consultant Neuro-oncologist.

Good prescribing practice for corticosteroids

Table 1 - Good Prescribing Practice for Corticosteroids – see more information on NHS Lothian Steroid Safety Bundle

1

Document indication for the corticosteroid on the patient’s notes.

Baseline HbA1C should be taken.  If known diabetic or HbA1c >/= 42, follow guidance in Lothian Steroid Safety Bundle (link above)

2

Steroids have long half-life so can be prescribed once a day after breakfast. If the patient prefers to have the dose split, then do not give after 14.00. Dexamethasone comes in 2mg and 0.5mg (500microgram) tablets.

3

Start gastric protection with a PPI (e.g. omeprazole 20mg od).

Note PPI increase risk of C Difficile and can cause hyponatraemia (if sodium drops swap PPI to famotidine) and stomatitis, so should be stopped 7 days after steroids (if no on-going GI symptoms)

4

Ensure appropriate patient information regarding corticosteroids (importance of not stopping suddenly, dietary advice) and dose reduction regimen on discharge. Counsel if necessary.

5

All patients should be given a STEROID EMERGENCY CARD and advised of ‘sick day rules’ - if have fever, infection needing antibiotics, undergoing surgical procedure etc

  • If taking 0.5-1.0mg Dexamethasone, double this dose whilst unwell or on day of procedure.
  • If taking 1.5mg Dexamethasone or higher – stay on same dose

If vomiting and unable to take steroids should attend hospital for IV/IM steroids

6

Monitor all patients on high dose steroids for:

  • Diabetes (NB sugars peak late afternoon) see Steroid Safety bundle for guidance on management of steroid induced diabetes
  • Dyspepsia/ epigastric pain
  • Mania/hypomania/psychosis

7

If taking 2mg or more dexamethasone for more than 3 months and patient has a reasonable prognosis consider oral bisphosphonates +/- vitamin D & calcium for prevention of osteoporosis

8

Consideration of Co-trimoxazole prophylaxis if patient has significant immunocompromise or co-existing respiratory conditions. See more information here

  • The steroid dose should be reviewed regularly, and if possible, reduced. This can be undertaken by oncologists, nurse specialists, palliative care team or GPs.
  • The speed of reduction will depend on interventions used (e.g. discontinuing after complete resection, or radiotherapy for radiosensitive tumour).
  • In general, they should be reduced by around 25% every one to two weeks to the lowest level at which the patient remains well.
  • It takes at least three days for the impact of reduced steroids to have an impact so symptoms within this period may not be related to steroid reduction.

 

Table 2: Examples of reducing course – speed depends on individual’s symptoms

Week

Mild Presentation

Moderate Presentation

Severe Presentation

1

4mg od

8mg od

8mg bd

2

3mg od

6mg od

6mg bd

3

2mg od

4mg od

4mg bd

4

1.5mg od

3mg od

6mg od

5

1mg od

2mg od

4mg od

6

0.5mg od

1.5mg od

3mg od

7

Stop*

1mg od

2mg od

8

 

0.5mg od

1.5mg od

9

 

Stop*

1mg od

10

 

 

0.5mg od

11

 

 

Stop*

 

If the patient struggles to come off steroids due to withdrawal symptoms (fatigue, aches and pains) options include: 

  • Alternate day dexamethasone 0.5mg alt day for two weeks.
  • Conversion to prednisolone (1mg dexamethasone = 7mg prednisolone) 
  • Synacthen test – liaise with endocrinology.

Editorial Information

Last reviewed: 09/05/2025

Next review date: 09/05/2028

Author(s): Edinburgh Cancer Centre, Western General Hospital, El-Shakankery K, Hopkins S, Erridge S.

Version: 1.0

Author email(s): karim.el-shakankery2@nhs.scot, samantha.hopkins@nhslothian.scot.nhs.uk.

Approved By: CTAC. Refer to Q-Pulse for approval details.

Reviewer name(s): Stewart J.